PD-1 antibody-based therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PD-1 antibody-based therapy, covering 2026-03-20 to 2026-03-20. Get the full timeline:
Most recent: Clinical Trial Update: PD-1 Antibody-based Therapy With Concurrent RT for Early-stage NKTCL [Phase 2]